Nutex Health, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67079U1088
USD
156.79
27.02 (20.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
211.79
257.62
78.79
76.08
67.45
69.67
62.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
211.79
257.62
78.79
76.08
67.45
69.67
62.72
Raw Material Cost
93.45
115.99
56.88
53.52
57.30
56.46
55.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.12
5.05
5.38
5.05
4.44
4.24
4.10
Selling and Distribution Expenses
46.13
27.43
11.83
10.59
8.71
9.14
7.84
Other Expenses
-0.61
-0.51
-0.54
-0.51
-0.44
-0.42
-0.41
Total Expenditure (Excl Depreciation)
139.58
143.42
68.71
64.11
66.00
65.59
63.50
Operating Profit (PBDIT) excl Other Income
72.2
114.2
10.1
12
1.4000000000000001
4.1
-0.8
Other Income
-3.33
-0.04
-0.13
0.60
0.24
-0.33
0.05
Operating Profit (PBDIT)
73.98
119.44
14.93
17.10
5.88
8.43
4.02
Interest
6.12
5.05
5.38
5.05
4.44
4.24
4.10
Exceptional Items
0.00
-0.52
-7.16
-3.61
2.60
-30.22
-0.04
Gross Profit (PBDT)
118.34
141.63
21.92
22.56
10.16
13.21
7.07
Depreciation
5.09
5.28
4.97
4.53
4.19
4.68
4.75
Profit Before Tax
62.76
108.58
-2.58
3.90
-0.15
-30.71
-4.87
Tax
18.54
8.61
4.58
0.89
0.39
-3.00
-0.34
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
14.63
61.70
-8.79
-0.36
-0.36
-31.62
-5.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
14.63
61.70
-8.79
-0.36
-0.36
-31.62
-5.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
29.59
38.27
1.62
3.37
-0.18
3.91
1.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.22
99.97
-7.17
3.01
-0.54
-27.71
-4.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
197.11
146.34
60.44
62.73
63.02
61.45
89.93
Earnings per share (EPS)
2.56
11.12
-1.72
-0.05
-0.07
-7.01
-1.25
Diluted Earnings per share
2.56
11.12
-1.72
-0.05
-0.07
-7.01
-1.25
Operating Profit Margin (Excl OI)
34.09%
44.33%
12.8%
15.73%
2.15%
5.85%
-1.24%
Gross Profit Margin
32.04%
44.2%
3.04%
11.09%
5.98%
-37.36%
-0.19%
PAT Margin
6.91%
23.95%
-11.15%
-0.48%
-0.54%
-45.38%
-8.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is -17.78% vs 226.90% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is -55.80% vs 1,488.89% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is -35.31% vs 691.39% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is 19.61% vs -5.56% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

Compare Quarterly Results Of Nutex Health, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
211.79
5.65
206.14
3,648.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
211.79
5.65
206.14
3,648.50%
Raw Material Cost
93.45
3.65
89.80
2,460.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.12
0.02
6.10
30,500.00%
Selling and Distribution Expenses
46.13
2.83
43.30
1,530.04%
Other Expenses
-0.61
-0.00
-0.61
Total Expenditure (Excl Depreciation)
139.58
6.48
133.10
2,054.01%
Operating Profit (PBDIT) excl Other Income
72.21
-0.82
73.03
8,906.10%
Other Income
-3.33
0.78
-4.11
-526.92%
Operating Profit (PBDIT)
73.98
0.38
73.60
19,368.42%
Interest
6.12
0.02
6.10
30,500.00%
Exceptional Items
0.00
0.14
-0.14
-100.00%
Gross Profit (PBDT)
118.34
2.01
116.33
5,787.56%
Depreciation
5.09
0.42
4.67
1,111.90%
Profit Before Tax
62.76
0.07
62.69
89,557.14%
Tax
18.54
0.00
18.54
Provisions and contingencies
0
0
0.00
Profit After Tax
14.63
0.07
14.56
20,800.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
14.63
0.07
14.56
20,800.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
29.59
0.00
29.59
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.22
0.07
44.15
63,071.43%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
197.11
12.29
184.82
1,503.82%
Earnings per share (EPS)
2.56
0.05
2.51
5,020.00%
Diluted Earnings per share
2.56
0.05
2.51
5,020.00%
Operating Profit Margin (Excl OI)
34.09%
-14.57%
0.00
48.66%
Gross Profit Margin
32.04%
8.77%
0.00
23.27%
PAT Margin
6.91%
1.31%
0.00
5.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21.18 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -17.78% vs 226.90% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 213.78% vs 19.89% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.42 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -55.80% vs 1,488.89% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 8,940.00% vs 92.75% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.73 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -35.31% vs 691.39% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 1,280.36% vs 2,900.00% in Mar 2024

Quarterly - Interest
Interest 0.61 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 19.61% vs -5.56% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 38.64% vs 41.94% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.09%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has improved from Mar 2024